U.S. top court takes no action in Teva MS drug case

[riky]

U.S. top court takes no action in Teva MS drug case

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday for the second time did not announce whether it would hear an appeal by Teva Pharmaceutical Industries Ltd in a patent fight with generic competitors over a top-selling multiple sclerosis drug. The nine justices are considering whether to review a July 2013 ruling by the U.S. Court of Appeals for the Federal Circuit in favor of two teams developing cheaper generic forms of Copaxone. Novartis AG's Sandoz Inc and Momenta Pharmaceuticals Inc are developing one drug and Mylan Inc and Natco Pharma Ltd are working on the other. The appeals court upheld some of nine patents involved in the drug, or parts of them, but declared several invalid, meaning patent protections expire this May instead of September 2015.

Source: You are not allowed to view links. Register or Login